BSE filing, NSE: TRANSCHEM. Summary written from the filing by ALFA Finder's alert engine.
Transchem Ltd: key numbers
- Share price
- ₹416.10
- Market cap
- ₹509.3 Cr
- Revenue (annual)
- ₹0.00 Cr
- Net profit (annual)
- ₹4.30 Cr
- P/E (TTM)
- 75.8×Sector 26.2×
- Promoter holding
- 56.45%+0.00% QoQ
- FII holding
- 0.03%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Transchem Ltd
All →Transchem Board Meeting Date
Transchem Ltd intimated BSE that its Board meeting is scheduled for November 4, 2026 to consider un-audited Q2/H1 results. The trading window for designated persons is closed from October 1, 2026.
Transchem Other Announcement
Transchem Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026. The submission includes minor composition updates to the company's promoter group.
Transchem Annual General Meeting
Transchem Limited submitted the minutes of its 49th Annual General Meeting held on September 05, 2026. Shareholders approved audited financial statements and the re-appointment of Director Mahesh Suresh Rananavre.
Transchem Annual General Meeting
Transchem Limited held its 49th Annual General Meeting on September 05, 2026. Members considered agenda items, including financial statement adoption and related party transaction approvals.
Transchem Merger & Restructuring Worth ₹25.91 Cr
Transchem Limited has executed a Share Purchase Agreement to acquire 100% of Greshma Shares and Stocks Limited for ₹25.91 Crore. The acquired entity becomes a wholly-owned subsidiary.
- Value
- ₹25.91 Cr
Transchem Other Announcement
Transchem Limited has amended its 'Code of Conduct for Prevention of Insider Trading' in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015.
Other board meeting date announcements
All →Indowind Energy Board Meeting Date
Indowind Energy scheduled a board meeting on 5 Nov 2026 to approve Q1 FY27 unaudited results. The trading window remains closed until 48 hours post-approval.
Dhunseri Ventures Board Meeting Date
Dhunseri Ventures Ltd intimated that its Board will meet on 6 November 2026, inter alia to approve Q2 FY27 results. The trading window stays closed until 8 November 2026.
CESC Board Meeting Date
CESC Ltd scheduled its Board Meeting for 5 Nov 2026 to consider Q2/H1 FY27 unaudited results. No financial figures or decisions are reported in this advance intimation.
Genpharmasec Board Meeting Date
Genpharmasec Ltd will hold a Board meeting on 03 Nov 2026. Agenda includes proposing approval of Q2/H1 FY27 unaudited results.
Hexa Tradex Board Meeting Date
Hexa Tradex scheduled its board meeting for November 5, 2026, to approve Q2 FY27 unaudited financial results. Trading window closes until 48 hours post-disclosure.
Ampvolts Board Meeting Date
Ampvolts Ltd has scheduled its Board meeting for November 6, 2026, to approve unaudited Q2/H1 FY27 results. No financial figures are disclosed in this prior intimation.